ALX Oncology Holdings Inc (ALXO) stock
ALXONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$1.06+0.04 (+3.92%)
Close on Nov 20, 2026Market cap $146.57MP/E –Yield –
ALX Oncology price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
ALX Oncology's price to sales ratio was 34.3× on Oct 30, 2020.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2020 | Oct 30, 2020 | 34.3× | – |
See a number that looks wrong?